Viemed Healthcare (NASDAQ: VMD) is one of 27 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it weigh in compared to its peers? We will compare Viemed Healthcare to similar companies based on the strength of its dividends, valuation, earnings, risk, institutional ownership, analyst recommendations and profitability.
This is a summary of recent recommendations and price targets for Viemed Healthcare and its peers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Viemed Healthcare Competitors||92||389||536||15||2.46|
Institutional and Insider Ownership
51.1% of Viemed Healthcare shares are held by institutional investors. Comparatively, 44.3% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by institutional investors. 15.2% of Viemed Healthcare shares are held by company insiders. Comparatively, 25.5% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Viemed Healthcare has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500. Comparatively, Viemed Healthcare’s peers have a beta of 7.02, meaning that their average stock price is 602% more volatile than the S&P 500.
This table compares Viemed Healthcare and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Viemed Healthcare Competitors||-39.15%||16.05%||-9.95%|
Earnings & Valuation
This table compares Viemed Healthcare and its peers gross revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Viemed Healthcare||$131.31 million||$31.53 million||9.36|
|Viemed Healthcare Competitors||$1.94 billion||$96.17 million||39.86|
Viemed Healthcare’s peers have higher revenue and earnings than Viemed Healthcare. Viemed Healthcare is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Viemed Healthcare beats its peers on 7 of the 13 factors compared.
About Viemed Healthcare
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.